+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hypopigmentation Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4851501
  • Report
  • February 2019
  • Region: Global
  • 178 pages
  • Transparency Market Research
1 of 2

Global Hypopigmentation Disorder Treatment Market: Overview

This report analyzes the current and future scenario of the global hypopigmentation disorder treatment market. Increase in patient population with hypopigmentation disorders, growth of the pharmaceutical industry, improvement in health care infrastructure, and increase in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global hypopigmentation disorder treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global hypopigmentation disorder treatment market.

Global Hypopigmentation Disorder Treatment Market: Key Segments

Based on treatment, the global hypopigmentation disorder treatment market has been segmented into topical drugs, laser therapy, chemical peels, microdermabrasion, and others (phototherapy, etc.). The segments have been analyzed based on available drug products used in the treatment of hypopigmentation disorders, cost-effectiveness, and preference for industries. In terms of diseases indication, the market has been classified into vitiligo, albinism, and others. Based on end-user, the global hypopigmentation disorder treatment market has been classified into hospitals, aesthetic clinics & dermatology centers, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Hypopigmentation Disorder Treatment Market: Regional Outlook

In terms of region, the global hypopigmentation disorder treatment market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global hypopigmentation disorder treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Allergan, SkinCeuticals, Pierre Fabre, Episciences, Inc., RXi Pharmaceuticals Corporation, Obagi Cosmeceuticals LLC (Obagi Medical), and Alvogen.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Market Overview
4.2. Global Hypopigmentation Disorders Treatment Market Analysis
4.3. Global Hypopigmentation Disorders Treatment Market Overview
4.4. Porter’s Five Forces Analysis
4.5. Pipeline Analysis
4.6. Key Partnership & Acquisitions
4.7. Disease Prevalence and Incidence: Global Overview
4.8. Regulatory Scenario

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends

6. Global Hypopigmentation Disorders Treatment Market Analysis, by Treatment
6.1. Introduction
6.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Treatment
6.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Treatment
6.4. Global Hypopigmentation Disorders Treatment Market Analysis, by Treatment
6.4.1. Topical Drugs
6.4.2. Laser Therapy
6.4.3. Chemical Peels
6.4.4. Microdermabrasion
6.4.5. Others (phototherapy, etc.)
6.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Treatment

7. Global Hypopigmentation Disorders Treatment Market Analysis, by Disease Indication
7.1. Introduction
7.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Disease Indication
7.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
7.4. Global Hypopigmentation Disorders Treatment Market Analysis, by Disease Indication
7.4.1. Vitiligo
7.4.2. Albinism
7.4.3. Others
7.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis

8. Global Hypopigmentation Disorders Treatment Market Analysis, by End-user
8.1. Introduction
8.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by End-user
8.3. Global Hypopigmentation Disorders Treatment Market Forecast, by End-user
8.4. Global Hypopigmentation Disorders Treatment Market Analysis, by End-user
8.4.1. Hospitals
8.4.2. Aesthetic Clinics & Dermatology Centers
8.4.3. Others
8.5. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by End-user

9. Global Hypopigmentation Disorders Treatment Market Analysis, by Region
9.1. Global Market Scenario
9.2. Global Hypopigmentation Disorders Treatment Market Value Share Analysis, by Region
9.3. Global Hypopigmentation Disorders Treatment Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Hypopigmentation Disorders Treatment Market Attractiveness Analysis, by Region

10. North America Hypopigmentation Disorders Treatment Market Analysis
10.1. North America Hypopigmentation Disorders Treatment Market Analysis
10.2. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country
10.3. North America Hypopigmentation Disorders Treatment Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
10.5. North America Hypopigmentation Disorders Treatment Market Forecast, by Treatment
10.5.1. Topical Drugs
10.5.2. Laser Therapy
10.5.3. Chemical Peels
10.5.4. Microdermabrasion
10.5.5. Others (phototherapy, etc.)
10.6. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
10.7. North America Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
10.7.1. Vitiligo
10.7.2. Albinism
10.7.3. Others
10.8. North America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
10.8.1. Hospitals
10.8.2. Aesthetic Clinics & Dermatology Centers
10.8.3. Others

11. Europe Hypopigmentation Disorders Treatment Market Analysis
11.1. Europe Hypopigmentation Disorders Treatment Market Analysis
11.2. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
11.5. Europe Hypopigmentation Disorders Treatment Market Forecast, by Treatment
11.5.1. Topical Drugs
11.5.2. Laser Therapy
11.5.3. Chemical Peels
11.5.4. Microdermabrasion
11.5.5. Others (phototherapy, etc.)
11.6. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
11.7. Europe Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
11.7.1. Vitiligo
11.7.2. Albinism
11.7.3. Others
11.8. Europe Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
11.8.1. Hospitals
11.8.2. Aesthetic Clinics & Dermatology Centers
11.8.3. Others

12. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis
12.1. Asia Pacific Hypopigmentation Disorders Treatment Market Analysis
12.2. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
12.3.1. China
12.3.2. Japan
12.3.3. India
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
12.5. Asia Pacific Hypopigmentation Disorders Treatment Market Forecast, by Treatment
12.5.1. Topical Drugs
12.5.2. Laser Therapy
12.5.3. Chemical Peels
12.5.4. Microdermabrasion
12.5.5. Others (phototherapy, etc.)
12.6. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
12.7. Asia Pacific Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
12.7.1. Vitiligo
12.7.2. Albinism
12.7.3. Others
12.8. Asia Pacific Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
12.8.1. Hospitals
12.8.2. Aesthetic Clinics & Dermatology Centers
12.8.3. Others

13. Latin America Hypopigmentation Disorders Treatment Market Analysis
13.1. Latin America Hypopigmentation Disorders Treatment Market Analysis
13.2. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
13.5. Latin America Hypopigmentation Disorders Treatment Market Forecast, by Treatment
13.5.1. Topical Drugs
13.5.2. Laser Therapy
13.5.3. Chemical Peels
13.5.4. Microdermabrasion
13.5.5. Others (phototherapy, etc.)
13.6. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
13.7. Latin America Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
13.7.1. Vitiligo
13.7.2. Albinism
13.7.3. Others
13.8. Latin America Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
13.8.1. Hospitals
13.8.2. Aesthetic Clinics & Dermatology Centers
13.8.3. Others

14. Middle East & Africa Hypopigmentation Disorders Treatment Market Analysis
14.1. Middle East & Africa Hypopigmentation Disorders Treatment Market Analysis
14.2. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Hypopigmentation Disorders Treatment Market Forecast, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Rest of MEA
14.4. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Treatment
14.5. Middle East & Africa Hypopigmentation Disorders Treatment Market Forecast, by Treatment
14.5.1. Topical Drugs
14.5.2. Laser Therapy
14.5.3. Chemical Peels
14.5.4. Microdermabrasion
14.5.5. Others (phototherapy, etc.)
14.6. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by Disease Indication
14.7. Middle East & Africa Hypopigmentation Disorders Treatment Market Forecast, by Disease Indication
14.7.1. Vitiligo
14.7.2. Albinism
14.7.3. Others
14.8. Middle East & Africa Hypopigmentation Disorders Treatment Market Value Share and Attractiveness Analysis, by End-user
14.8.1. Hospitals
14.8.2. Aesthetic Clinics & Dermatology Centers
14.8.3. Others

15. Competition Landscape
15.1. Hypopigmentation Disorders Treatment Market Share Analysis, by Company
15.2. Competition Matrix
15.3. Company Profile
15.3.1. Allergan
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. SkinCeuticals
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Pierre Fabre
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Episciences, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Rxi Pharmaceutical Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Obagi Cosmeceuticals LLC (Obagi Medical)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Alvogen
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll